Caseware UK (AP4) 2022.0.179 2022.0.179 2022-12-312022-12-31true2022-01-018The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.falseNo description of principal activity5false 05419875 2022-01-01 2022-12-31 05419875 2021-01-01 2021-12-31 05419875 2022-12-31 05419875 2021-12-31 05419875 2021-01-01 05419875 c:RestatedAmount 2021-01-01 05419875 d:Director1 2022-01-01 2022-12-31 05419875 d:Director2 2022-01-01 2022-12-31 05419875 d:Director2 2022-12-31 05419875 d:RegisteredOffice 2022-01-01 2022-12-31 05419875 c:ComputerEquipment 2022-01-01 2022-12-31 05419875 c:ComputerEquipment 2022-12-31 05419875 c:ComputerEquipment 2021-12-31 05419875 c:ComputerEquipment c:OwnedOrFreeholdAssets 2022-01-01 2022-12-31 05419875 c:ComputerSoftware 2022-12-31 05419875 c:ComputerSoftware 2021-12-31 05419875 c:OtherResidualIntangibleAssets 2022-01-01 2022-12-31 05419875 c:CurrentFinancialInstruments 2022-12-31 05419875 c:CurrentFinancialInstruments 2021-12-31 05419875 c:Non-currentFinancialInstruments 2022-12-31 05419875 c:Non-currentFinancialInstruments 2021-12-31 05419875 c:CurrentFinancialInstruments c:WithinOneYear 2022-12-31 05419875 c:CurrentFinancialInstruments c:WithinOneYear 2021-12-31 05419875 c:Non-currentFinancialInstruments c:AfterOneYear 2022-12-31 05419875 c:Non-currentFinancialInstruments c:AfterOneYear 2021-12-31 05419875 c:Non-currentFinancialInstruments c:BetweenOneTwoYears 2022-12-31 05419875 c:Non-currentFinancialInstruments c:BetweenOneTwoYears 2021-12-31 05419875 c:Non-currentFinancialInstruments c:BetweenTwoFiveYears 2022-12-31 05419875 c:Non-currentFinancialInstruments c:BetweenTwoFiveYears 2021-12-31 05419875 c:ShareCapital 2022-01-01 2022-12-31 05419875 c:ShareCapital 2022-12-31 05419875 c:ShareCapital 2021-01-01 2021-12-31 05419875 c:ShareCapital 2021-12-31 05419875 c:ShareCapital 2021-01-01 05419875 c:SharePremium 2022-01-01 2022-12-31 05419875 c:SharePremium 2022-12-31 05419875 c:SharePremium 2021-01-01 2021-12-31 05419875 c:SharePremium 2021-12-31 05419875 c:SharePremium 2021-01-01 05419875 c:SharePremium c:RestatedAmount 2021-01-01 05419875 c:CapitalRedemptionReserve 2022-01-01 2022-12-31 05419875 c:CapitalRedemptionReserve 2022-12-31 05419875 c:CapitalRedemptionReserve 2021-01-01 2021-12-31 05419875 c:CapitalRedemptionReserve 2021-12-31 05419875 c:CapitalRedemptionReserve 2021-01-01 05419875 c:CapitalRedemptionReserve c:RestatedAmount 2021-01-01 05419875 c:RetainedEarningsAccumulatedLosses 2022-01-01 2022-12-31 05419875 c:RetainedEarningsAccumulatedLosses 2022-12-31 05419875 c:RetainedEarningsAccumulatedLosses 2021-01-01 2021-12-31 05419875 c:RetainedEarningsAccumulatedLosses 2021-12-31 05419875 c:RetainedEarningsAccumulatedLosses 2021-01-01 05419875 c:RetainedEarningsAccumulatedLosses c:RestatedAmount 2021-01-01 05419875 d:OrdinaryShareClass1 2022-01-01 2022-12-31 05419875 d:OrdinaryShareClass1 2022-12-31 05419875 d:OrdinaryShareClass1 2021-12-31 05419875 d:FRS102 2022-01-01 2022-12-31 05419875 d:AuditExempt-NoAccountantsReport 2022-01-01 2022-12-31 05419875 d:FullAccounts 2022-01-01 2022-12-31 05419875 d:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 05419875 2 2022-01-01 2022-12-31 05419875 6 2022-01-01 2022-12-31 05419875 c:ComputerSoftware c:OwnedIntangibleAssets 2022-01-01 2022-12-31 05419875 c:SharePremium c:PriorPeriodErrorIncreaseDecrease 2021-01-01 2021-12-31 05419875 c:CapitalRedemptionReserve c:PriorPeriodErrorIncreaseDecrease 2021-01-01 2021-12-31 05419875 c:RetainedEarningsAccumulatedLosses c:PriorPeriodErrorIncreaseDecrease 2021-01-01 2021-12-31 05419875 c:PriorPeriodErrorIncreaseDecrease 2021-01-01 2021-12-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 05419875









GENACTIS GROUP LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2022

 
GENACTIS GROUP LIMITED
 
 
COMPANY INFORMATION


Directors
T R S Denne 
C T Edmonds (resigned 12 December 2022)




Registered number
05419875



Registered office
316a Beulah Hill

London

United Kingdom

SE19 3HF




Accountants
Donald Reid Limited
Chartered Accountants

Prince Albert House

20 King Street

Maidenhead

Berkshire

SL6 1DT





 
GENACTIS GROUP LIMITED
 

CONTENTS



Page
Balance sheet
1 - 2
Statement of changes in equity
3
Notes to the financial statements
4 - 12


 
GENACTIS GROUP LIMITED
REGISTERED NUMBER: 05419875

BALANCE SHEET
AS AT 31 DECEMBER 2022

2022
2021
Note
£
£

Fixed assets
  

Intangible assets
 4 
26,228
29,665

Tangible assets
 5 
4,307
3,226

Investments
 6 
38,555
38,555

  
69,090
71,446

Current assets
  

Debtors: amounts falling due within one year
 7 
44,788
692,974

Cash at bank and in hand
 8 
50,057
5,896

  
94,845
698,870

Creditors: amounts falling due within one year
 9 
(437,663)
(606,732)

Net current (liabilities)/assets
  
 
 
(342,818)
 
 
92,138

Total assets less current liabilities
  
(273,728)
163,584

Creditors: amounts falling due after more than one year
 10 
(24,503)
(34,881)

  

Net (liabilities)/assets
  
(298,231)
128,703


Capital and reserves
  

Called up share capital 
 12 
1,107
1,107

Share premium account
  
230,699
230,699

Capital redemption reserve
  
35
35

Profit and loss account
  
(530,072)
(103,138)

  
(298,231)
128,703


Page 1

 
GENACTIS GROUP LIMITED
REGISTERED NUMBER: 05419875
    
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2022

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 31 October 2023.




T R S Denne
Director

The notes on pages 4 to 12 form part of these financial statements.

Page 2

 
GENACTIS GROUP LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2022


Called up share capital
Share premium account
Capital redemption reserve
Profit and loss account
Total equity

£
£
£
£
£


At 1 January 2021
1,139
239,607
-
34,516
275,262

Prior year adjustment
-
-
-
(10,140)
(10,140)


At 1 January 2021
1,139
239,607
-
24,376
265,122


Comprehensive income for the year

Loss for the year

-
-
-
(127,514)
(127,514)
Total comprehensive income for the year
-
-
-
(127,514)
(127,514)

Purchase of own shares
-
-
35
-
35

Shares redeemed during the year
(32)
(8,908)
-
-
(8,940)


Total transactions with owners
(32)
(8,908)
35
-
(8,905)



At 1 January 2022
1,107
230,699
35
(103,138)
128,703


Comprehensive income for the year

Loss for the year

-
-
-
(426,934)
(426,934)
Total comprehensive income for the year
-
-
-
(426,934)
(426,934)


Total transactions with owners
-
-
-
-
-


At 31 December 2022
1,107
230,699
35
(530,072)
(298,231)


The notes on pages 4 to 12 form part of these financial statements.

Page 3

 
GENACTIS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

1.


General information

Genactis Group Limited is a private company limited by shares. The company was incorporated in the United Kingdom and is registered in England and Wales. The registered number is 05419875. The registered address is 316a Beulah Hill, London, United Kingdom, SE19 3HF.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Exemption from preparing consolidated financial statements

The Company, and the Group headed by it, qualify as small as set out in section 383 of the Companies Act 2006 and the parent and Group are considered eligible for the exemption to prepare consolidated accounts.

 
2.3

Going concern

At the year end, the company had net liabilities of £298,231 (2021 net assets: £128,703). In order to enable the company to remain a going concern, the director will continue to provide financial support at least one year from the date of signing the balance sheet as required. The director therefore considers it appropriate to use the going concern basis.

 
2.4

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Profit and loss account within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 4

 
GENACTIS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

2.Accounting policies (continued)

 
2.5

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.6

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Profit and loss account in the same period as the related expenditure.

 
2.7

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.8

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.9

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 5

 
GENACTIS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

2.Accounting policies (continued)

 
2.10

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.11

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 Amortisation is provided on the following bases:

Computer software
-
10%
straight line

 
2.12

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Computer equipment
-
33%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.13

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Page 6

 
GENACTIS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

2.Accounting policies (continued)

 
2.14

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.15

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.16

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.17

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Profit and loss account.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date.

Financial assets and liabilities are offset and the net amount reported in the Balance sheet when
Page 7

 
GENACTIS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

2.Accounting policies (continued)


2.17
Financial instruments (continued)

there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.


3.


Employees

The average monthly number of employees, including directors, during the year was 8 (2021 - 5).


4.


Intangible assets




Computer software

£



Cost


At 1 January 2022
34,380



At 31 December 2022

34,380



Amortisation


At 1 January 2022
4,715


Charge for the year on owned assets
3,437



At 31 December 2022

8,152



Net book value



At 31 December 2022
26,228



At 31 December 2021
29,665



Page 8

 
GENACTIS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

5.


Tangible fixed assets





Computer equipment

£



Cost or valuation


At 1 January 2022
5,162


Additions
3,187



At 31 December 2022

8,349



Depreciation


At 1 January 2022
1,936


Charge for the year on owned assets
2,106



At 31 December 2022

4,042



Net book value



At 31 December 2022
4,307



At 31 December 2021
3,226


6.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 January 2022
38,555



At 31 December 2022
38,555




During the year, the company incorporated Genactis Health Panels Limited with share capital of £0.01. The company is the only shareholder of Genactis Health Panels Limited.

Page 9

 
GENACTIS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

7.


Debtors

2022
2021
£
£


Trade debtors
11,051
444,565

Amounts owed by group undertakings
27,392
236,881

Other debtors
2,978
-

Prepayments and accrued income
3,367
11,528

44,788
692,974



8.


Cash and cash equivalents

2022
2021
£
£

Cash at bank and in hand
50,057
5,896

Less: bank overdrafts
(852)
(3,001)

49,205
2,895



9.


Creditors: Amounts falling due within one year

2022
2021
£
£

Bank overdrafts
852
3,001

Bank loans
10,498
10,121

Trade creditors
38,081
54,264

Amounts owed to group undertakings
111,490
82,832

Other taxation and social security
29,237
72,235

Other creditors
202,521
88,739

Accruals and deferred income
44,984
295,540

437,663
606,732


Page 10

 
GENACTIS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

10.


Creditors: Amounts falling due after more than one year

2022
2021
£
£

Bank loans
24,503
34,881

24,503
34,881



11.


Loans


Analysis of the maturity of loans is given below:


2022
2021
£
£

Amounts falling due within one year

Bank loans
10,498
10,121


10,498
10,121

Amounts falling due 1-2 years

Bank loans
10,638
10,376


10,638
10,376

Amounts falling due 2-5 years

Bank loans
13,865
24,505


13,865
24,505


35,001
45,002



12.


Share capital

2022
2021
£
£
Allotted, called up and fully paid



110,690 (2021 - 110,690) Ordinary shares of £0.01 each
1,107
1,107


Page 11

 
GENACTIS GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

13.


Related party transactions

The company has taken advantage of the exemptions from some of the requirements in Section 33 Related Party Disclosures from disclosing transactions with other members of the group.

 
Page 12